Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study
Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.03.6400
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2006
Authors
Publisher
American Society of Clinical Oncology (ASCO)